EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Lentiviral miR ‐200a Mimics in Regulating Fibrinolysis and EMT Markers During Pulmonary Fibrosis

T M Jeena, C Rakshitha, Akarsha B Jain, Vaishnavi, Fathima Razana, Aleena Varughese, M Fathimath Muneesa, Yashodhar P Bhandary iD

FASEB BioAdvances · 2026-04 · 8 (4)

DOI: 10.1096/fba.2025-00276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FASEB BioAdvances, online erschienen am 17.04.2026. Verfasst von T M Jeena und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology & Molecular Genetics Division, Yenepoya Research Centre, Yenepoya Deemed to be University Mangalore Karnataka India. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by the excessive accumulation of collagen‐rich extracellular matrix (ECM), leading to the replacement of normal lung architecture. This pathological remodeling is primarily caused by the epithelial‐to‐mesenchymal transition (EMT), in which epithelial cells lose their polarity and adhesion and acquire mesenchymal characteristics that encourage the deposition of ECM and the growth of fibrotic tissue. The disruption of ECM homeostasis caused by dysregulated MMP‐2 and MMP‐9 activity in IPF paradoxically promotes abnormal tissue remodeling and fibrosis. IPF's unknown etiology, delayed diagnosis, and lack of effective treatments point to a crucial knowledge gap regarding ECM‐ and EMT‐driven fibrosis. The microRNA‐200 (miR‐200) family has been found to be important EMT regulators in recent research, suggesting that they may be able to influence the course of fibrosis. Hereby the current study provides an insight on the role of miR‐200a in regulating MMP‐2 and MMP‐9 in bleomycin (BLM)‐induced lung fibrosis using both in vitro (A549 cells) and in vivo (C57BL/6 mice) models. A549 cells were transfected with a synthetic miR‐200a mimic, and MMP expression was analyzed using RT‐qPCR. In vivo, mice were intranasally administered a lentiviral vector expressing miR‐200a prior to BLM induction, followed by tissue analysis at days 14 and 21 using histological stains and immunofluorescence. Gene and protein expression were quantified via RT‐qPCR and western blotting. Our findings indicate that miR‐200a mitigates fibrosis by downregulating MMPs and PAI‐1 while upregulating uPA and uPAR, suggesting a protective role of miR‐200a and its potential as a therapeutic target for pulmonary fibrosis.

Schlagwörter

Stichwörter der Autor:innen

ECMIPFMMPsfibrosis regulationlentiviral transfectionmiR‐200a

Autor:innen und Institutionen

  • Cell Biology & Molecular Genetics Division, Yenepoya Research Centre, Yenepoya Deemed to be University Mangalore Karnataka India.
  • The University of Texas Health Science Centre Fort Worth Texas USA.
  • Department of Bioscience Mangalore University Mangalore Karnataka India.
  • IQRAA Hospital & Research Centre Calicut Kerala India.
  • Specialized Research Unit, Yenepoya Medical College & Hospital, Yenepoya Deemed to be University Mangalore Karnataka India.

ORCID-Profile: Yashodhar P Bhandary

Zitieren

APA

Jeena, T. M., Rakshitha, C., Jain, A. B., Vaishnavi, Razana, F., Varughese, A., Fathimath Muneesa, M., & Bhandary, Y. P. (2026). Therapeutic Potential of Lentiviral miR ‐200a Mimics in Regulating Fibrinolysis and EMT Markers During Pulmonary Fibrosis. FASEB BioAdvances, 8(4). https://doi.org/10.1096/fba.2025-00276

Vancouver

Jeena TM, Rakshitha C, Jain AB, Vaishnavi, Razana F, Varughese A, et al. Therapeutic Potential of Lentiviral miR ‐200a Mimics in Regulating Fibrinolysis and EMT Markers During Pulmonary Fibrosis. FASEB BioAdvances. 2026;8(4). doi:10.1096/fba.2025-00276

BibTeX
@article{Jeena2026,
  author = {Jeena, T M and Rakshitha, C and Jain, Akarsha B and Vaishnavi and Razana, Fathima and Varughese, Aleena and Fathimath Muneesa, M and Bhandary, Yashodhar P},
  title = {Therapeutic Potential of Lentiviral miR ‐200a Mimics in Regulating Fibrinolysis and EMT Markers During Pulmonary Fibrosis},
  journal = {FASEB BioAdvances},
  year = {2026},
  volume = {8},
  number = {4},
  doi = {10.1096/fba.2025-00276}
}
Kostenlos starten →